dr. cohen on the potential of btk inhibitors in frontline treatment of mcl
Published 6 years ago • 93 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:56
dr. rule on the role of btk inhibitors in mcl
-
1:07
dr. cohen discusses the treatment of mcl
-
0:41
dr. goy on the potential utility of btk inhibitors as maintenance in mcl
-
1:29
dr. wang on the benefit of btk inhibitors in mcl
-
59:49
rebooting the btk inhibitor sequence in mcl
-
1:22
dr. cohen on the evolution of antibodies in lymphoma
-
1:47
dr. leslie on the role of btk inhibitors in relapsed/refractory mcl
-
3:57
btk inhibitors in chronic lymphocytic leukemia
-
1:21
dr koff on the role of covalent btk inhibitors and pirtobrutinib in mcl
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
5:59
differentiating btk inhibitor mechanisms of action in mcl
-
3:11
immunotherapeutic options for patients with mcl who progress on btk inhibitors
-
1:05
dr. fenske on the utility of next-generation btk inhibitors in mcl
-
4:16
mcl: differences in trial design between btk inhibitors
-
1:47
challenges in using car-t therapy & btk inhibitors in patients with r/r mcl
-
2:09
the optimal sequencing of novel therapies in mantle cell lymphoma
-
2:40
btk inhibitors for r/r mcl: current uses and insights from the vipor study
-
4:13
mcl: novel btk inhibitor combination strategies